Skip to main content
. 2018 Jun 6;16(2):2143–2150. doi: 10.3892/ol.2018.8909

Table I.

Sequences of primers were used in this study.

Gene name Sequence
GPR124 Reverse: 5′-GGTCGTTCTACTGGGCTGATT-3′
Forward: 5′-AGCAAGAGGGGATTTCACAAT-3′
TIMP-1 Forward: 5′-GTCAGTGAGAAGCAAGTCGA-3′
Reverse: 5′-ATGTTCTTCTCTGTGACCCA-3′
TIMP-2 Forward: 5′-TGGGGACACCAGAAGTCAAC-3′
Reverse: 5′-TTTTCAGAGCCTTGGAGGAG-3′
MMP-3 Reverse: 5′-CTTCTTCAAGGACCGGTCA-3′
Forward: 5′-GCTGGCTGAGTACCAGTA-3′
MMP-9 Reverse: 5′-TGGGCTACGTGACCTATGAC-3′
Forward: 5′-GCCCAGCCCACCTCCACTCC-3′
VEGF Reverse: 5′-GCACCCATGGCAGAAGGAGGAG-3′
Forward: 5′-GTGCTGACGCTAACTGACC-3′
Endostatin Forward: 5′-ATGCACAGCCACCGCGACTT-3′
Reverse: 5′-CTTCATGACTGCCTCCAAGTAG-3′
Bcl-2 Forward: 5′-CTCAGCCAGCCAGTGACATA-3′
Reverse: 5′-CCGTGCTCCAGATACAT-3′
Bcl-w Forward: 5′-AGAGTGGACCACACTGCGC-3′
Reverse: 5′-ACATCCCAACGGTCATCGTA-3′
Bax Reverse: 5′-GGAGGGGATCAGTATATACA-3′
Forward: 5′-GAAGATGGAGAGATGG-3′
Caspase-3 Reverse: 5′-CTGTGAGATCACTGGCTTTG-3′
Forward: 5′-TTGGAGGGAACAGACGAG-3′
CDK1 Reverse: 5′-ACAGTGCATCATCGCTGTTC-3′
Forward: 5′-CCGGAGAGGAGACTTCACAG-3′
Cyclin-B1 Reverse: 5′-GAAAGCATCCAGCAATAGGC-3′
Forward: 5′-TAAGGAAGCCTGGAGCACAG-3′
P27 Reverse: 5′-CATGGTGAAACCCCGTCTCTA-3′
Forward: 5′-GCCTCAGCCTCCCGAGTAG-3′
MDR1 Reverse: 5′-GGGCAGAATCTTTCCACCA-3′
Forward: 5′-TTAAATGTATACCCAAAGACAA-3′
LRP Reverse: 5′-CGAATGGGTGTTTTCACATATG-3′
Forward: 5′-CTTCAATTGTATTCAGGATGG-3′
TS Reverse: 5′-CACCCTCAATATTTGGAA-3′
Forward: 5′-CCGTTGTTGTAGGACTAATGAA-3′
β-actin Reverse: 5′-CGGAGTCAACGGATTTGGTC-3′
Forward: 5′-AGCCTTCTCCATGGTCGTGA-3′

GPR124, G-protein coupled receptor 124; TIMP, TIMP metallopeptidase inhibitor; MMP, matrix metallopeptidase; VEGF, vascular endothelial growth factor; Bcl, B-cell lymphoma; Bax, Bcl-2 associated X, apoptosis regulator; CDK1, cyclin dependent kinase 1; MDR1, ATP binding cassette subfamily B member 1; LRP, LDL receptor related protein.